InvestorsHub Logo
Followers 2
Posts 90
Boards Moderated 0
Alias Born 11/12/2020

Re: pzottkpz post# 527

Sunday, 02/28/2021 11:17:19 AM

Sunday, February 28, 2021 11:17:19 AM

Post# of 807
Just to be clear, I am only disputing the short covering potential for this stock. I have no problem with the science or market potential of the drug.

People should be aware, however, that KMPH has already sold the rights to the drug to a private company. KMPH will be entitled to royalties and milestone payments along the way, but we don't have a lot of definition (other than the total) of the milestone payments or their timing. KMPH no longer has control of the development, manufacturing, or marketing of the drug. The bulk of the profits will be earned by Gurnet Point Capital and its subsidiary Corium International. The royalty/milestone payments may well make KMPH a winner in the future. It's just hard to value it at the moment (for me).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KMPH News